Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D001714', 'term': 'Bipolar Disorder'}, {'id': 'D000087122', 'term': 'Mania'}], 'ancestors': [{'id': 'D000068105', 'term': 'Bipolar and Related Disorders'}, {'id': 'D019964', 'term': 'Mood Disorders'}, {'id': 'D001523', 'term': 'Mental Disorders'}, {'id': 'D019954', 'term': 'Neurobehavioral Manifestations'}, {'id': 'D009461', 'term': 'Neurologic Manifestations'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C428744', 'term': '10,11-dihydro-10-hydroxy-5H-dibenz(b,f)azepine-5-carboxamide'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE4'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NA', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 181}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2004-12'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2017-03', 'completionDateStruct': {'date': '2007-07', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2017-03-24', 'studyFirstSubmitDate': '2005-08-29', 'studyFirstSubmitQcDate': '2005-08-29', 'lastUpdatePostDateStruct': {'date': '2017-03-28', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2005-08-31', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2007-07', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Safety and tolerability of treatment with licarbazepine over 52 weeks.'}, {'measure': 'with respect to the rates of adverse events and serious adverse events, as well as changes in laboratory values, ECGs and vital signs.'}]}, 'conditionsModule': {'keywords': ['Bipolar disorder, manic episode/treatment/licarbazepine'], 'conditions': ['Bipolar Disorder']}, 'descriptionModule': {'briefSummary': 'This extension study is designed to assess the long-tem tolerability and safety of licarbazepine in patients who completed the 6-week double-blind study CLIC477D2303.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '70 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* written informed consent provided prior to participation in the extension study\n* successful completion of study CLIC477D2303\n* cooperation and willingness to comply with all study requirements\n\nExclusion Criteria:\n\n* premature discontinuation from study CLIC477D2303\n* failure to comply with study CLIC477D2303'}, 'identificationModule': {'nctId': 'NCT00139594', 'briefTitle': 'Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder', 'organization': {'class': 'INDUSTRY', 'fullName': 'Novartis'}, 'officialTitle': 'A 52-week, Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder', 'orgStudyIdInfo': {'id': 'CLIC477D2303E1'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'licarbazepine', 'interventionNames': ['Drug: licarbazepine']}], 'interventions': [{'name': 'licarbazepine', 'type': 'DRUG', 'armGroupLabels': ['licarbazepine']}]}, 'contactsLocationsModule': {'locations': [{'zip': '20623', 'city': 'La Palma', 'state': 'California', 'country': 'United States', 'facility': 'Investigational site', 'geoPoint': {'lat': 33.8464, 'lon': -118.04673}}, {'city': 'Kansas City', 'state': 'Kansas', 'country': 'United States', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 39.11417, 'lon': -94.62746}}, {'city': 'Shreveport', 'state': 'Louisiana', 'country': 'United States', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 32.52515, 'lon': -93.75018}}, {'city': 'Somerville', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 42.3876, 'lon': -71.0995}}, {'city': 'Farmington Hills', 'state': 'Michigan', 'country': 'United States', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 42.48531, 'lon': -83.37716}}, {'city': 'Staten Island', 'state': 'New York', 'country': 'United States', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 40.56233, 'lon': -74.13986}}, {'city': 'Madison', 'state': 'Tennessee', 'country': 'United States', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 36.25616, 'lon': -86.71389}}, {'city': 'Bellaire', 'state': 'Texas', 'country': 'United States', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 29.70579, 'lon': -95.45883}}, {'city': 'Dallas', 'state': 'Texas', 'country': 'United States', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 32.78306, 'lon': -96.80667}}, {'city': 'Verdun', 'state': 'Texas', 'country': 'United States', 'facility': 'Novartis Investigational Site'}, {'city': 'Bellevue', 'state': 'Washington', 'country': 'United States', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 47.61038, 'lon': -122.20068}}, {'city': 'Kirkland', 'state': 'Washington', 'country': 'United States', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 47.68149, 'lon': -122.20874}}, {'city': 'West Allis', 'state': 'Wisconsin', 'country': 'United States', 'facility': 'Novartis Investigational site', 'geoPoint': {'lat': 43.01668, 'lon': -88.00703}}, {'city': 'Vienna', 'country': 'Austria', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 48.20849, 'lon': 16.37208}}, {'city': 'Greater Sudbury', 'country': 'Canada', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 46.49, 'lon': -80.99001}}, {'city': 'Kelowna', 'country': 'Canada', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 49.88307, 'lon': -119.48568}}, {'city': 'London', 'country': 'Canada', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 42.98339, 'lon': -81.23304}}, {'city': 'Montreal', 'country': 'Canada', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'city': 'Vancouver', 'country': 'Canada', 'facility': 'Novartis Investigator Site', 'geoPoint': {'lat': 49.24966, 'lon': -123.11934}}, {'city': 'Bogotá', 'country': 'Colombia', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 4.60971, 'lon': -74.08175}}, {'city': 'Medellín', 'country': 'Colombia', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 6.245, 'lon': -75.57151}}, {'city': 'Pareira', 'country': 'Colombia', 'facility': 'Novartis Investigational Site'}, {'city': 'Brno', 'country': 'Czechia', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 49.19522, 'lon': 16.60796}}, {'city': 'Hradec Králové', 'country': 'Czechia', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 50.20923, 'lon': 15.83277}}, {'city': 'Prague', 'country': 'Czechia', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'city': 'Berlin', 'country': 'Germany', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'city': 'Bochum', 'country': 'Germany', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 51.48165, 'lon': 7.21648}}, {'city': 'Dresden', 'country': 'Germany', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 51.05089, 'lon': 13.73832}}, {'city': 'Ingolstadt', 'country': 'Germany', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 48.76508, 'lon': 11.42372}}, {'city': 'Mannheim', 'country': 'Germany', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 49.4891, 'lon': 8.46694}}, {'city': 'Würzburg', 'country': 'Germany', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 49.79391, 'lon': 9.95121}}, {'city': 'Guatemala City', 'country': 'Guatemala', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 14.64072, 'lon': -90.51327}}, {'city': 'Lima', 'country': 'Peru', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': -12.04318, 'lon': -77.02824}}, {'city': 'Moscow', 'country': 'Russia', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 55.75204, 'lon': 37.61781}}, {'city': 'Yaroslavl', 'country': 'Russia', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 57.62987, 'lon': 39.87368}}, {'city': 'Bojnice', 'country': 'Slovakia', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 48.78511, 'lon': 18.5864}}, {'city': 'Michalovce', 'country': 'Slovakia', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 48.75434, 'lon': 21.9195}}, {'city': 'Durban', 'country': 'South Africa', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': -29.8579, 'lon': 31.0292}}, {'city': 'Dnipro', 'country': 'Ukraine', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 48.46664, 'lon': 35.04066}}, {'city': 'Kiev', 'country': 'Ukraine', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 50.45466, 'lon': 30.5238}}, {'city': 'Luhansk', 'country': 'Ukraine', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 48.56814, 'lon': 39.30553}}, {'city': 'Odesa', 'country': 'Ukraine', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 46.48572, 'lon': 30.74383}}, {'city': 'Simferopol', 'country': 'Ukraine', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 44.95719, 'lon': 34.11079}}, {'city': 'Caracas', 'country': 'Venezuela', 'facility': 'Novartis Investigational Site', 'geoPoint': {'lat': 10.48801, 'lon': -66.87919}}], 'overallOfficials': [{'name': 'Novartis Pharmaceuticals', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Novartis Pharmaceuticals'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Novartis', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}